Literature DB >> 19263198

Pancreatic cancer surveillance among high-risk populations: knowledge and intent.

Zoe K Lewis1, Caren J Frost, Vickie L Venne.   

Abstract

Pancreatic cancer is the fourth most common cancer in both men and women in the United States. It has the lowest survival rate of all cancers, largely due to the presence of non-specific symptoms, leading to diagnosis at advanced stages. While the majority of cases of pancreatic cancer are sporadic, up to 10% may be associated with an inherited predisposition. Currently, there is no standard screening protocol for pancreatic cancer, although this will change in the future as technology improves. Additionally, there is little information regarding the perceptions and intent to screen for pancreatic cancer among those with an increased risk due to a hereditary cancer predisposition syndrome, which was the objective of this study. Focus groups and individual telephone interviews were conducted, with questions focused on knowledge about pancreatic cancer and screening, perceived motivators, and perceived barriers related to each of the screening techniques currently available. Participants were recruited from the High Risk Breast Cancer and Pancreatic Cancer Registries at Huntsman Cancer Institute. The findings of this study indicated that individuals from these high-risk groups have low knowledge levels of pancreatic cancer screening, despite their desire for this information. Motivation to undergo a particular screening technique is related to whether the test is recommended by a physician, cost, degree of invasiveness, and comfort level. This information is useful to genetics professionals who counsel at-risk individuals, physicians who formulate patient care plans, and translational researchers who are developing pancreatic screening methods.

Entities:  

Mesh:

Year:  2009        PMID: 19263198     DOI: 10.1007/s10897-008-9205-9

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  49 in total

1.  Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Authors:  Randall E Brand; Markus M Lerch; Wendy S Rubinstein; John P Neoptolemos; David C Whitcomb; Ralph H Hruban; Teresa A Brentnall; Henry T Lynch; Marcia I Canto
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

Review 2.  Familial pancreatic cancer: a review.

Authors:  H T Lynch; T Smyrk; S E Kern; R H Hruban; C J Lightdale; S J Lemon; J F Lynch; L R Fusaro; R M Fusaro; P Ghadirian
Journal:  Semin Oncol       Date:  1996-04       Impact factor: 4.929

3.  Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).

Authors:  H F Vasen; N A Gruis; R R Frants; P A van Der Velden; E T Hille; W Bergman
Journal:  Int J Cancer       Date:  2000-09-15       Impact factor: 7.396

4.  Long-term survival after surgical resection for pancreatic cancer.

Authors:  K Yoshizawa; H Nagai; K Kurihara; N Sata; T Kawai; K Saito
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

5.  High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

Authors:  A Borg; T Sandberg; K Nilsson; O Johannsson; M Klinker; A Måsbäck; J Westerdahl; H Olsson; C Ingvar
Journal:  J Natl Cancer Inst       Date:  2000-08-02       Impact factor: 13.506

Review 6.  Identification of high-risk pancreatic cancer-prone families.

Authors:  Randall E Brand; Henry T Lynch
Journal:  Gastroenterol Clin North Am       Date:  2004-12       Impact factor: 3.806

Review 7.  Management strategies for patients with hereditary pancreatic cancer.

Authors:  Teresa A Brentnall
Journal:  Curr Treat Options Oncol       Date:  2005-09

Review 8.  Screening and surveillance approaches in familial pancreatic cancer.

Authors:  Marcia Irene Canto
Journal:  Gastrointest Endosc Clin N Am       Date:  2008-07

9.  The evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients.

Authors:  T Frebourg; E Bercoff; N Manchon; J Senant; J P Basuyau; P Breton; A Janvresse; P Brunelle; J Bourreille
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

10.  Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography.

Authors:  Antonio Soriano; Antoni Castells; Carmen Ayuso; Juan Ramón Ayuso; Maria Teresa de Caralt; Maria Angels Ginès; Maria Isabel Real; Rosa Gilabert; Llorenç Quintó; Antoni Trilla; Faust Feu; Xavier Montanyà; Laureano Fernández-Cruz; Salvador Navarro
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

View more
  10 in total

Review 1.  Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

Authors:  Gabriele Lami; Maria Rosa Biagini; Andrea Galli
Journal:  World J Gastrointest Endosc       Date:  2014-07-16

Review 2.  Advances in Hereditary Colorectal and Pancreatic Cancers.

Authors:  Meghan L Underhill; Katharine A Germansky; Matthew B Yurgelun
Journal:  Clin Ther       Date:  2016-04-02       Impact factor: 3.393

Review 3.  Inherited pancreatic cancer syndromes.

Authors:  Sheila Solomon; Siddhartha Das; Randall Brand; David C Whitcomb
Journal:  Cancer J       Date:  2012 Nov-Dec       Impact factor: 3.360

4.  Long-term positive psychological outcomes in an Australian pancreatic cancer screening program.

Authors:  R S O'Neill; B Meiser; S Emmanuel; D B Williams; A Stoita
Journal:  Fam Cancer       Date:  2020-01       Impact factor: 2.375

5.  Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history.

Authors:  Carmen Radecki Breitkopf; Pamela S Sinicrope; Kari G Rabe; Tabetha A Brockman; Christi A Patten; Robert R McWilliams; Shawna Ehlers; Gloria M Petersen
Journal:  Hered Cancer Clin Pract       Date:  2012-06-27       Impact factor: 2.857

6.  Pancreatic cystic neoplasms: Adherence to management recommendations and associated endosonographic cyst characteristics.

Authors:  Athanasios Sioulas; Marianna Spinou; Dimitrios Schizas; Maria Megapanou; Maximos Frountzas; Konstantina Papadaki; Ilias Scotiniotis
Journal:  Saudi J Gastroenterol       Date:  2022 Mar-Apr       Impact factor: 2.485

7.  Patient experiences living with pancreatic cancer risk.

Authors:  Meghan Underhill; Donna Berry; Emily Dalton; Jaclyn Schienda; Sapna Syngal
Journal:  Hered Cancer Clin Pract       Date:  2015-05-21       Impact factor: 2.857

8.  German National Case Collection for familial pancreatic Cancer (FaPaCa) - acceptance and psychological aspects of a pancreatic cancer screening program.

Authors:  Frederike S Franke; Elvira Matthäi; Emily P Slater; Christoph Schicker; Johannes Kruse; Detlef K Bartsch
Journal:  Hered Cancer Clin Pract       Date:  2018-11-29       Impact factor: 2.857

Review 9.  Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview.

Authors:  Nilabja Sikdar; Gourab Saha; Ashmita Dutta; Shibajyoti Ghosh; Shailesh V Shrikhande; Sudeep Banerjee
Journal:  Curr Genomics       Date:  2018-09       Impact factor: 2.236

Review 10.  Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review.

Authors:  Irina Mihaela Cazacu; Adriana Alexandra Luzuriaga Chavez; Adrian Saftoiu; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2019 Jan-Feb       Impact factor: 5.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.